AWH insider transaction filings
Aspira Women's Health Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-05-27. Screen AWH transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for AWH between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Aspira Women's Health Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-05-27 | 4 | Buhle Michael William — Chief Executive Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Vos Ellen O'Connor — Director | Option exercise (M): 5,313 @ $0 · Option exercise (M): 5,313 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Beausang Ellen — Director | Option exercise (M): 1,615 @ $0 · Option exercise (M): 1,615 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Beausang Ellen — Director | Grant/award (A): 6,458 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Ragard John Phillip — Director | Option exercise (M): 4,843 @ $0 · Option exercise (M): 4,843 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Parnell Winfred — Director | Option exercise (M): 5,156 @ $0 · Option exercise (M): 5,156 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Herchuk Jannie Prestridge — Director | Option exercise (M): 8,438 @ $0 · Option exercise (M): 8,438 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Fralick Celeste Rachelle — Director | Option exercise (M): 5,000 @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Cavanaugh Stefanie L. — Director | Option exercise (M): 5,938 @ $0 · Option exercise (M): 5,938 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | SCHULER JACK W — 10% owner | Purchase (P) @ $200,000 | EDGAR |
| 2025-01-29 | 4/A | Milligan Sandra — Interim CEO | Option exercise (M): 20,000 @ $0 · Tax withholding (F): 6,356 @ $0.70 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Ragard John Phillip — Director | Option exercise (M): 4,844 @ $0 · Option exercise (M): 4,844 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Parnell Winfred — Director | Option exercise (M): 5,157 @ $0 · Option exercise (M): 5,157 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Herchuk Jannie Prestridge — Director | Option exercise (M): 8,437 @ $0 · Option exercise (M): 8,437 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Fralick Celeste Rachelle — Director | Option exercise (M): 5,000 @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Milligan Sandra — Interim CEO & President | Option exercise (M): 20,000 @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Cavanaugh Stefanie L. — Director | Option exercise (M): 5,937 @ $0 · Option exercise (M): 5,937 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Vos Ellen O'Connor — Director | Option exercise (M): 5,312 @ $0 · Option exercise (M): 5,312 (derivative) @ $0 | EDGAR |
| 2024-11-22 | 4/A | Ragard John Phillip — Director | Option exercise (M): 4,844 @ $0 · Option exercise (M): 4,844 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | Kallassy John A — Interim CFO | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | Milligan Sandra — President | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-10-28 | 4 | Milligan Sandra — President | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-10-28 | 4 | Sandford Nicole — Chief Executive Officer, Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Vos Ellen O'Connor — Director | Option exercise (M): 5,313 @ $0 · Option exercise (M): 5,313 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Ragard John Phillip — Director | Option exercise (M): 4,844 @ $0 · Option exercise (M): 4,844 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Parnell Winfred — Director | Option exercise (M): 5,156 @ $0 · Option exercise (M): 5,156 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Herchuk Jannie Prestridge — Director | Option exercise (M): 8,438 @ $0 · Option exercise (M): 8,438 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Fralick Celeste Rachelle — Director | Option exercise (M): 5,000 @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Cavanaugh Stefanie L. — Director | Option exercise (M): 5,938 @ $0 · Option exercise (M): 5,938 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | Ragard John Phillip — Director | Grant/award (A): 19,375 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | Parnell Winfred — Director | Grant/award (A): 20,625 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | Herchuk Jannie Prestridge — Director | Grant/award (A): 33,750 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | Fralick Celeste Rachelle — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | Cavanaugh Stefanie L. — Director | Grant/award (A): 23,750 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | Vos Ellen O'Connor — Director | Grant/award (A): 21,250 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | Kallassy John A — Interim CFO | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Parnell Winfred — Director | Grant/award (A): 15,803 @ $0 | EDGAR |
| 2024-08-13 | 4 | Herchuk Jannie Prestridge — Director | Grant/award (A): 20,017 @ $0 | EDGAR |
| 2024-08-13 | 4 | Fralick Celeste Rachelle — Director | Grant/award (A): 15,381 @ $0 | EDGAR |
| 2024-08-13 | 4 | Cavanaugh Stefanie L. — Director | Grant/award (A): 16,804 @ $0 | EDGAR |
| 2024-08-13 | 4 | Vos Ellen O'Connor — Director | Grant/award (A): 16,593 @ $0 | EDGAR |
| 2024-07-11 | 4 | SCHULER JACK W — 10% owner | Purchase (P): 6,536 · Purchase (P): 6,536 (derivative) | EDGAR |
| 2024-07-10 | 4 | Parnell Winfred — Director | Grant/award (A): 3,268 · Grant/award (A): 3,268 (derivative) | EDGAR |
| 2024-07-10 | 4 | Herchuk Jannie Prestridge — Director | Grant/award (A): 4,902 · Grant/award (A): 4,902 (derivative) | EDGAR |
| 2024-07-10 | 4 | Vos Ellen O'Connor — Director | Grant/award (A): 3,268 · Grant/award (A): 3,268 (derivative) | EDGAR |
| 2024-07-09 | 4 | Sandford Nicole — CEO, Director | Grant/award (A): 13,072 · Grant/award (A): 13,072 (derivative) | EDGAR |
| 2024-07-09 | 4 | Cavanaugh Stefanie L. — Director | Grant/award (A): 3,268 · Grant/award (A): 3,268 (derivative) | EDGAR |
| 2024-06-18 | 4 | SCHULER JACK W — 10% owner | Purchase (P): 28,500 · Purchase (P): 28,500 (derivative) | EDGAR |
| 2024-06-14 | 4 | Hombeck Torsten — Chief Financial Officer | Grant/award (A): 6,667 (derivative) @ $3.20 | EDGAR |
| 2024-06-03 | 4 | Sandford Nicole — Chief Executive Officer, Director | Purchase (P): 9,493 @ $2.42 | EDGAR |
Recent 8-K events — Aspira Women's Health Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-25 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-31 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AWH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →